ARGX
Argenx SE
Commercial-stage biopharmaceutical company developing antibody therapies for autoimmune diseases
ADRUnderlying: ARGXCUSIP: 04016X101HealthcareNL1 holder
Sponsored American Depositary Receipt (ADR) representing ordinary shares of argenx SE
Total Value
$157.71M
Total Shares
536.3K
Net Share Change
+536.3K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Lone Pine Capital
$157.71M536.3K sharesNEW